How did VVOS's recent EPS compare to expectations?
The most recent EPS for Vivos Therapeutics Inc is $-0.52, beating expectations of $-0.46.
How did Vivos Therapeutics Inc VVOS's revenue perform in the last quarter?
Vivos Therapeutics Inc revenue for the last quarter is $-0.52
What is the revenue estimate for Vivos Therapeutics Inc?
According to 5 of Wall street analyst, the revenue estimate of Vivos Therapeutics Inc range from $7.37M to $5.39M
What's the earning quality score for Vivos Therapeutics Inc?
Vivos Therapeutics Inc has a earning quality score of B+/50.81232. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Vivos Therapeutics Inc report earnings?
Vivos Therapeutics Inc next earnings report is expected in 2026-08-18
What are Vivos Therapeutics Inc's expected earnings?
Vivos Therapeutics Inc expected earnings is $4.3M, according to wall-street analysts.
Did Vivos Therapeutics Inc beat earnings expectations?
Vivos Therapeutics Inc recent earnings of $5.14M beat expectations.
Key Stats
Prev.Close
$0.3931
Open
$0.417
Day's Range
$0.3864 - $0.417
52 week range
$0.383 - $7.95
Volume
46.5K
Avg.Volume
1.2M
Dividend yield
--
EPS (TTM)
-2.12
Market Cap
$5.4M
What is VVOS?
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 109 full-time employees. The company went IPO on 2020-12-11. The firm calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The company comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service, and others.